References

A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance

10.1016/j.cmet.2009.02.002 · 2009 · External reference

Metabolite profiles and the risk of developing diabetes

10.1038/nm.2307 · 2011 · External reference

Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans

10.1172/jci44442 · 2011 · External reference

Role of ceramides in the pathogenesis of diabetes mellitus and its complications

10.1016/j.jdiacomp.2020.107734 · 2021 · External reference

Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance

10.2337/db08-1228 · 2009 · External reference

Amino acid signature predictive of incident prediabetes: a case–control study nested within the longitudinal pathobiology of prediabetes in a biracial cohort

10.1016/j.metabol.2019.06.011 · 2019 · External reference

Association of plasma acylcarnitines with insulin sensitivity, insulin secretion, and prediabetes in a biracial cohort

10.1177/15353702211009493 · 2021 · External reference

Plasma ceramides and other sphingolipids in relation to incident prediabetes in a longitudinal biracial cohort

10.1210/clinem/dgae179 · 2024 · External reference

Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach

10.2337/db12-0495 · 2013 · External reference

Circulating ceramides predict cardiovascular outcomes in the population-based FINRISK 2002 cohort

10.1161/atvbaha.116.307497 · 2016 · External reference

Metabolomic profile associated with insulin resistance and conversion to diabetes in the insulin resistance atherosclerosis study

10.1210/jc.2014-2357 · 2015 · External reference

Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity

10.1038/oby.2009.510 · 2010 · External reference

Acylcarnitines: nomenclature, biomarkers, therapeutic potential, drug targets, and clinical trials

10.1124/pharmrev.121.000408 · 2022 · External reference

Inflammation, metaflammation and immunometabolic disorders

10.1038/nature21363 · 2017 · External reference

Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity

10.1038/msb.2008.50 · 2008 · External reference

Improved insulin sensitivity after exercise training is linked to reduced plasma C14:0 ceramide in obesity and type 2 diabetes

10.1002/oby.21117 · 2015 · External reference

Changes in serum sphingomyelin after roux-en-Y gastric bypass surgery are related to diabetes status

10.3389/fendo.2018.00172 · 2018 · External reference

Differential metabolic impact of gastric bypass surgery versus dietary intervention in obese diabetic subjects despite identical weight loss

10.1126/scitranslmed.3002043 · 2011 · External reference

Regression from prediabetes to normal glucose regulation: state of the science

10.1177/1535370220915644 · 2020 · External reference

Pathobiology and reversibility of prediabetes in a biracial cohort (PROP-ABC) study: design of lifestyle intervention

10.1136/bmjdrc-2019-000899 · 2020 · External reference

Outcome of lifestyle intervention in relation to duration of pre-diabetes: the Pathobiology and Reversibility of Prediabetes in a Biracial Cohort (PROP-ABC) study

10.1136/bmjdrc-2021-002748 · 2022 · External reference

Pathobiology of prediabetes in a biracial cohort (POP-ABC) study: baseline characteristics of enrolled subjects

10.1210/jc.2012-2902 · 2013 · External reference

Plasma lipid levels predict dysglycemia in a biracial cohort of nondiabetic subjects: potential mechanisms

10.1177/1535370216659946 · 2016 · External reference

Lack of racial disparity in incident prediabetes and glycemic progression among black and white offspring of parents with type 2 diabetes: the pathobiology of prediabetes in a biracial cohort (POP-ABC) study

10.1210/jc.2014-1077 · 2014 · External reference

The Look AHEAD study: a description of the lifestyle intervention and the evidence supporting it

10.1038/oby.2006.84 · 2006 · External reference

Physical activity and weight loss: does prescribing higher physical activity goals improve outcome?

10.1093/ajcn/78.4.684 · 2003 · External reference

2. Diagnosis and Classification of Diabetes: standards of care in diabetes—2026

10.2337/dc26-s002 · 2026 · External reference

Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp

10.2337/diacare.22.9.1462 · 1999 · External reference

Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin

10.2337/diabetes.54.8.2404 · 2005 · External reference

Quantification of the relationship between insulin sensitivity and β-cell function in human subjects. Evidence for a hyperbolic function

10.2337/diab.42.11.1663 · 1993 · External reference

Quantitative analysis of sphingolipids for lipidomics using triple quadrupole and quadrupole linear ion trap mass spectrometers

10.1194/jlr.d800051-jlr200 · 2009 · External reference

Plasma dihydroceramides are diabetes susceptibility biomarker candidates in mice and humans

10.1016/j.celrep.2017.02.019 · 2017 · External reference

Ceramide stearic to palmitic acid ratio predicts incident diabetes

10.1007/s00125-018-4590-6 · 2018 · External reference

Associations among circulating sphingolipids, β-cell function, and risk of developing type 2 diabetes: a population-based cohort study in China

10.1371/journal.pmed.1003451 · 2020 · External reference

Selective association of plasma sphingolipid species with insulin sensitivity and secretion in normoglycemic Black and White American adults

10.3389/ebm.2025.10538 · 2025 · External reference

Plasma sphingolipids in relation to glycemia and glucose tolerance in people without diabetes

10.1210/clinem/dgaf378 · 2026 · External reference

Skeletal muscle and plasma lipidomic signatures of insulin resistance and overweight/obesity in humans

10.1002/oby.21448 · 2016 · External reference

Exercise increases adiponectin levels and insulin sensitivity in humans

10.2337/diacare.27.2.629 · 2004 · External reference

Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin

10.1210/jcem.86.8.7741 · 2001 · External reference

Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin

10.1038/nm.2277 · 2011 · External reference

Serum levels of acylcarnitines are altered in prediabetic conditions

10.1371/journal.pone.0082459 · 2013 · External reference

Unresolved reference

2000 · External reference

Recent advances in the pathophysiology of fatty acid oxidation defects: secondary alterations of bioenergetics and mitochondrial calcium homeostasis caused by the accumulating fatty acids

10.3389/fgene.2020.598976 · 2020 · External reference

Clinical and biochemical outcomes of patients with medium-chain acyl-CoA dehydrogenase deficiency

10.1016/j.ymgme.2019.11.006 · 2020 · External reference

Human protein metabolism: its measurement and regulation

10.1152/ajpendo.00337.2002 · 2002 · External reference

Insulin resistance and the metabolism of branched-chain amino acids

10.1007/s11684-013-0255-5 · 2013 · External reference

Metabolites associated with abnormal glucose metabolism responding to primary care lifestyle intervention

10.1038/s41598-025-25749-z · 2025 · External reference